Physician profile

Harold Rodner

Internal Medicine · Southfield, MI

NPI 1861477432

$1,078.94

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $321.90 2019-2022
Sanofi-Aventis U.S. LLC $113.42 2019-2021
Novo Nordisk INC $105.66 2019-2021
Amarin Pharma, INC. $82.71 2019-2020
Novartis Pharmaceuticals Corporation $76.83 2021-2022
Abbvie INC. $72.52 2019
Dexcom, INC. $66.94 2021
Bayer Healthcare Pharmaceuticals INC. $52.34 2021
Boehringer Ingelheim Pharmaceuticals, INC. $40.71 2019-2021
Astellas Pharma US INC $34.62 2019
Merck Sharp & Dohme LLC $23.46 2021
Glaxosmithkline, LLC. $17.80 2020
Biohaven Pharmaceuticals, INC. $16.98 2021
Janssen Pharmaceuticals, INC $14.82 2022
Valeritas, INC. $13.83 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Abbott Laboratories $12.43 2019
Pfizer INC. $11.97 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Harold Rodner

$1,078.94

in general payments reported 2019-2025

Years
2019-2022
Top company
Amgen INC.

https://glasscript.com/doctor/129986/harold-rodner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.